Tom E. Howard
ScholarGPS® ID: 31500136558897
Affiliation History
Field
Life Sciences
Discipline
Genetics
Top Specialties
Factor VIII | Angiotensin-converting Enzyme | Enzyme | Thrombosis | Coagulation
Metrics Summary
Publication Count
48
Predicted Citations
1,464
Predicted h-index
18
Ranking
Publications and Citation History
Publications based on Top Specialties
Types of Publication
- Publications
- Books
- Patents
- NIH/NSF
Add
Delete
|
---|
Blood, volume 142, issue Supplement 1, pages 1246-1246 (2023). |
Blood, volume 142, issue Supplement 1, pages 1247-1247 (2023). |
Blood, volume 140, issue Supplement 1, pages 8536-8537 (2022). |
Blood, volume 140, issue Supplement 1, pages 2799-2800 (2022). |
Blood, volume 138, issue Supplement 1, pages 3217-3217 (2021). |
Blood, volume 138, issue Supplement 1, pages 1059-1059 (2021). |
On the Role of Hemostasis Variables in Cardiometabolic Outcomes (journal article) Blood, volume 138, issue Supplement 1, pages 4266-4266 (2021). |
Genomic variations in patients with myelodysplastic syndrome and karyotypes without numerical or structural changes (journal article) Scientific Reports, volume 11, issue 1 (2021). |
Blood, volume 136, issue Supplement 1, pages 29-30 (2020). |
Journal of Thrombosis and Haemostasis, volume 18, issue 1, pages 201-216 (2020). |
Blood, volume 134, issue Supplement_1, pages 2393-2393 (2019). |
Peptides identified on monocyte-derived dendritic cells: a marker for clinical immunogenicity to FVIII products (journal article) Blood Advances, volume 3, issue 9, pages 1429-1440 (2019). |
Human Immunology, volume 79 (2018). |
Blood, volume 126, issue 23, pages 2292-2292 (2015). |
Patent Number: 20160045575 (2015) |
The intron-22–inverted F8 locus permits factor VIII synthesis: explanation for low inhibitor risk and a role for pharmacogenomics (journal article) Blood, volume 125, issue 2, pages 223-228 (2015). |
Blood, volume 124, issue 21, pages 4221-4221 (2014). |
British Journal of Haematology, volume 165, issue 1, pages 154-158 (2014). |
Blood, volume 122, issue 21, pages 2319-2319 (2013). |
Endogenous factor VIII synthesis from the intron 22–inverted F8 locus may modulate the immunogenicity of replacement therapy for hemophilia A (journal article) Nature Medicine, volume 19, issue 10, pages 1318-1324 (2013). |